Compounds > aluminum
Page last updated: 2024-08-26

aluminum and Influenza, Human

aluminum has been researched along with Influenza, Human in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fodor, K; Gonczol, E; Jankovics, I; Jankovics, M; Kis, Z; Kuti, D; Pallinger, E; Sarkadi, J; Visontai, I1
Chen, CH; Fang, CT; Lin, YJ; Shih, YJ1
Balaton, G; Kalabay, L; Rozsa, N; Torzsa, P; Vajo, P; Vajo, Z1
Basser, RL; Bennet, J; Formica, NT; Hartel, G; Höschler, K; McVernon, J; Nolan, T; Richmond, PC; Ryan, D; Sawlwin, DC; Skeljo, MV; Stoney, T; Zambon, MC1
Engelmann, H; Hehme, N; Kuenzel, W; Neumeier, E; Saenger, R1
Yokoi, T1

Reviews

1 review(s) available for aluminum and Influenza, Human

ArticleYear
Aluminum salts as an adjuvant for pre-pandemic influenza vaccines: a meta-analysis.
    Scientific reports, 2018, 07-30, Volume: 8, Issue:1

    Topics: Adjuvants, Immunologic; Aluminum; Antibodies, Neutralizing; Bias; Hemagglutination Inhibition Tests; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Salts

2018

Trials

3 trial(s) available for aluminum and Influenza, Human

ArticleYear
Licensing the first reduced, 6 µg dose whole virion, aluminum adjuvanted seasonal influenza vaccine - A randomized-controlled multicenter trial.
    Vaccine, 2019, 01-07, Volume: 37, Issue:2

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aluminum; Antibodies, Viral; Dosage Forms; Double-Blind Method; Female; Hemagglutination Inhibition Tests; Humans; Immunogenicity, Vaccine; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Licensure; Male; Middle Aged; Prospective Studies; Vaccination; Virion; Young Adult

2019
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
    Vaccine, 2008, Nov-25, Volume: 26, Issue:50

    Topics: Adjuvants, Immunologic; Aluminum; Antibodies, Viral; Child; Child, Preschool; Double-Blind Method; Female; Hemagglutination Inhibition Tests; Humans; Infant; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Neutralization Tests; Treatment Outcome

2008
Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Virus research, 2004, Volume: 103, Issue:1-2

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aluminum; Antibodies, Viral; Hemagglutination Inhibition Tests; Humans; Immunoglobulin A; Influenza A virus; Influenza Vaccines; Influenza, Human; Neuraminidase; Neutralization Tests

2004

Other Studies

2 other study(ies) available for aluminum and Influenza, Human

ArticleYear
Protection by humoral elements independent of virus neutralization activity against an influenza virus challenge.
    The new microbiologica, 2017, Volume: 40, Issue:3

    Topics: Adjuvants, Immunologic; Adoptive Transfer; Aluminum; Animals; Antibodies, Viral; Chickens; Female; Granzymes; Hemagglutination Tests; Humans; Immune Sera; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Interferon-gamma; Lung; Mice; Mice, Inbred BALB C; Neuraminidase; Neutralization Tests; RNA, Messenger

2017
[Studies on prophylactic effects of the aluminum adjuvant influenza virus hemagglutinin (HA) vaccine (author's transl)].
    Fukuoka igaku zasshi = Hukuoka acta medica, 1979, Volume: 70, Issue:6

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aluminum; Evaluation Studies as Topic; Hemagglutinins, Viral; Humans; Influenza Vaccines; Influenza, Human

1979